Pembrolizumab-associated anti-MDA5 dermatomyositis in a patient with lung cancer: a first case report. Swiss Med Wkly [Internet]. 2024 Mar. 4 [cited 2025 Oct. 14];154(3):3513. Available from: https://www.smw.ch/index.php/smw/article/view/3513